Cargando…
In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43
Previous data have suggested an antiviral effect of teriflunomide, including against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the agent underlying the ongoing COVID-19 pandemic. We undertook an in vitro investigation to evaluate the inhibitory activity of teriflunomide against S...
Autores principales: | Lang, Paul, Geertsen, Svend S., Lublin, Alex L., Potter, Michelle C., Gladysheva, Tatiana, Gregory, Jill S., Rufi, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682045/ https://www.ncbi.nlm.nih.gov/pubmed/36437966 http://dx.doi.org/10.1016/j.bbrep.2022.101395 |
Ejemplares similares
-
Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022) -
Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
por: Ottogalli, María Emilia, et al.
Publicado: (2021) -
Improved plaque assay for human coronaviruses 229E and OC43
por: Bracci, Nicole, et al.
Publicado: (2020) -
Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
por: Lee, Hyun-Kyoung, et al.
Publicado: (2010) -
Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)
por: Liu, Ding X., et al.
Publicado: (2021)